Login    Join free Add to favorites    中文
home > news > 4th Annual Clinical Development and Trials Asia Congress 鈥 Final Agenda Released
Industry Updates | New Products | Supplier News | Upcoming Events | business | web
4th Annual Clinical Development and Trials Asia Congress 鈥 Final Agenda Released

hits:1680     Date:11/21/14

Oxford Global are pleased to announce that the final agenda for the upcoming 4th Annual Clinical Development and Trials Asia Congress and co-located 5th Annual Pharma R&D Asia Congress has been released.
 
Taking place on the 27th & 28th January 2015 in Shanghai, China, over 170 industry leaders will offer invaluable insights into the changing regulatory environment in China and surrounding regions. Successful strategies and innovative technologies in enabling clinical development and clinical trial management will be discussed, with the Congress consisting of the following streams:
 
    鈼    Clinical Development Activities & Clinical Outsourcing Strategies
    鈼    Featured Technology Stream 鈥 Enabling Technologies for Drug Development and Personalised Medicine
    鈼    Clinical Trials Management Strategies in Asia and Asia Pacific Regions
    鈼    Innovation Strategies to Advance R&D in Asia
 
To view the agenda in full, please visit (http://www.clinicalasia-congress.com/download-agenda-marketing/)
 
Our dedicated research into the field ensures that we secure the very best quality speakers from top pharma companies and academic institutions to share their inspirational work with the conference attendees. We have insured that every speaker has a unique story to bring to the audience and that they will present the latest, most exciting work 鈥 highlighting any pitfalls they have made along the way. Confirmed speakers so far include:
 
    鈼    Zhengqing Li, VP and Head of China Development, MSD
    鈼    Cezary Statuch, Vice President of R&D, Bristol-Myers Squibb, China
    鈼    Dan Paulson, Vice President, Global Clinical Development, Group Head, Cardiovascular Risk Management and Women's HealthCare, Bayer HealthCare Company Limited Global R&D Centre
    鈼    Oliver Kong, Senior Director, Clinical Development Oncology, Celgene Corporation
    鈼    Akhilesh Sharma, Senior Vice President & Global Head Global Medical Affairs, Dr. Reddy's Laboratories India
    鈼    Victoria Elegant, Vice President of Medical & Regulatory Affairs, Baxter, China
 
To find out who else will be speaking at this two-day event, visit (http://www.clinicalasia-congress.com/who-is-speaking/)
 
In the run up to the 4th Annual Clinical Development and Trials Asia Congress, we have been speaking with members of our speaker panel to get their views on the clinical development and clinical trials industries and about the work they will be sharing at our Congress. To read our interviews with Dr. Cezary Statuch, Vice President of R&D, Bristol-Myers Squibb, China and Dr Hua Mu, Senior Vice President, Global Head of Product Development, Service and Partnership Business Unit, WuXi AppTec (Shanghai) Co., Ltd., please visit (http://www.clinicalasia-congress.com/who-is-speaking/q-a/)  
 
With only two months to go until registration closes, register your interest today to secure your place at the 4th Annual Clinical Development and Trials Asia Congress and co-located 5th Annual Pharma R&D Asia Congress. A limited number of Early Bird Discounts are available - contact Steph Punfield on +44 (0)1865 248455 or email s.punfield@oxfordglobal.co.uk  for more information on these prices and available discounts.
Related News>> more
advertisement

Copyright(C) 2006-2017 Bio-Equip    E-mail:web@bio-equip.cn   娌狪CP澶06040519鍙